Peru imported 9% more medicines in 2026, and Italy became its top supplier
Italy tripled its medicine shipments to Peru and passed India
Medicines imported into Peru by origin, 1 January to 27 September of each year. Source SUNAT.
All the figures
| Measure | 1 Jan to 27 Sep 2025 | 1 Jan to 27 Sep 2026 |
|---|---|---|
| Value imported | US$ 543M | US$ 594M |
| Tonnes | 26,990 | 30,932 |
| Price per kilo | US$ 20.11 | US$ 19.21 |
| Importers | 397 | 401 |
| From Italy | US$ 22M | US$ 69M |
| From India | US$ 70M | US$ 67M |
| Tecnofarma SA | US$ 34M | US$ 75M |
For a laboratory that sells in Peru, or wants to, these figures show who brings medicines in from abroad and from which country. In 2026 almost 31,000 tonnes entered the country, 15% more than the 27,000 of the same stretch of 2025. The value grew less than the weight because the average price per kilo fell 4%, from US$ 20.11 to US$ 19.21. The number of buyers barely moved, with 397 companies importing in the 2025 stretch and 401 in the 2026 one.
Italy tripled its shipments in one year
Between January 2025 and September 2026, India is the top origin, with 12% of the value. Germany, China and Italy follow, with 8% each. In 2026 the order changed. Italy went from US$ 22 million in the 2025 stretch to US$ 69 million, up 215%, and already supplies 12% of the value of the year. India fell 4%, to US$ 67 million, and came second.
The Italian kilo is worth US$ 318, one of the highest prices on the list, against US$ 31 for the Indian kilo and US$ 2.46 for the Chinese one. That gap reflects the kind of product each country sends. China ships a lot of weight at a low price, while Italy ships products of high value per kilo.
Italy is also the main 2026 origin for four of the largest importers, Tecnofarma SA, Inretail Pharma SA, Pfizer SA and Merck Peruana SA. France also grew, 35%, to US$ 22 million. The United States fell the most among the top ten origins, 12%, to US$ 30 million.
Tecnofarma more than doubled its medicine imports into Peru
Medicines imported by each company, 1 January to 27 September of each year. Source SUNAT.
Tecnofarma more than doubled its purchases
The ten largest importers account for 37% of the value since 2025, and the first one alone for 9%. That first one is Tecnofarma SA, with US$ 121 million since January 2025. In 2026 it stands at US$ 75 million, 120% more than in the same stretch of 2025.
Inretail Pharma SA grew even faster. It went from US$ 8 million to US$ 20 million, up 161%, and rose to fifth place for the year. Oqcorp SAC grew 57%, to US$ 21 million, with China as its main origin. Pfizer SA grew 48%, to US$ 17 million.
Other large buyers bought less. Astrazeneca Peru SA, second since January 2025, fell 19%, to US$ 27 million. Novartis Biosciences SA dropped 28%, and Laboratorios Americanos SA 25%. With that drop, Laboratorios Americanos SA slipped from eighth place in the cumulative ranking since 2025 to 12th in 2026.
Many companies come and go, but they move little money
There are 92 companies that imported medicines in 2025 and show no purchases in 2026. In 2025 they totalled US$ 10 million, and more than half belongs to a single one, Qs Consumo SAC, with almost US$ 7 million. On the other side, 64 companies imported for the first time in 2026, and together they add up to less than US$ 2 million. The largest is Pharma International Group Filial, with US$ 390,000 from Italy.
The real weight sits at the top. The 132 importers above US$ 1 million bring in 95% of the value. Small companies are many, but they change the total very little.
What to watch from here
Most likely, the growth of 2026 is explained by a few large buyers that increased their purchases from Italy, although nine months are not yet enough to know whether it is a lasting change of supplier or a one-off order from one or two companies.
Three things are worth following in the last quarter. Whether Tecnofarma SA and Inretail Pharma SA keep their pace. Whether Italy stays ahead of India when the year closes. And whether Astrazeneca Peru SA and Novartis Biosciences SA recover what they lost.
The 2026 figures run to 27 September and are compared with the same stretch of 2025. The country is the origin the importer declares at customs. Values are FOB, without freight or insurance.
For a laboratory that exports medicines to Peru, the starting point is the companies that already buy from its country and those that have just increased their purchases in 2026.
Source: SUNAT. Prepared by Garay Company.
Frequently asked questions
How much did Peru spend on imported medicines in 2026?
US$ 594 million up to 27 September 2026, 9% more than the US$ 543 million of the same stretch of 2025. Almost 31,000 tonnes entered the country.
Which country is the top supplier of medicines to Peru?
In 2026 it is Italy, with US$ 69 million and 12% of the value, after growing 215%. India came second with US$ 67 million.
Who is the largest medicine importer in Peru?
Tecnofarma SA, with US$ 121 million since January 2025 and US$ 75 million in 2026, 120% more than in the same stretch of 2025.
Which importers grew or fell the most?
Inretail Pharma SA grew 161%, Oqcorp SAC 57% and Pfizer SA 48%. Astrazeneca Peru SA fell 19% and Novartis Biosciences SA 28%.
How concentrated is the Peruvian medicine import market?
The ten largest importers hold 37% of the value since 2025, and the 132 importers above US$ 1 million bring in 95%.
Tell us what medicines you make. We come back with who imports them into Peru and from which country.
We read the Peruvian import record for a living. You get the companies already buying from your country and the ones that just increased their purchases.
Reply to info@garaycompany.comPrefer a sample first? Ask for one and it lands in your inbox.